参考文献/References:
[1] PDQ Adult Treatment Editorial Board. Pancreatic neuroendocrine tumors(islet cell tumors)treatment(PDQ):patient vesion[J].PDQ Cancer Information Summaries [Internet]. Bethesda(MD): National Cancer Institute(US); 2002-2018 Apr 19.
[2] 陆再英,钟南山,等.内科学//苗志敏.低血糖症[M].第7版.北京:人民卫生出版社,2008:795.
[3] Pallais JC,Blake MA,Deshpande V.Case records of the Massachusetts General Hospital.Case 33-2012. A 34-year-old woman with episodic paresthesias and altered mental status after childbirth[J].N Engl J Med,2012,367(17):1637-1646.DOI:10.1056/NEJMcpc1114037.
[4] Vanderveen K,Grant C.Insulinoma[J].Cancer Treat Res,2010,153:235-252.DOI:10.1007/978-1-4419-0857-5_13.
[5] Jensen RT,Berna MJ,Bingham DB,et al.Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies[J].Cancer,2008,113(7 Suppl):1807-1843.DOI:10.1002/cncr.23648.
[6] Kulke MH,Shah MH,Benson AB 3rd,et al.Neuroendocrine tumors, version 1.2015[J].J Natl Compr Canc Netw,2015,13(1):78-108.DOI:10.6004/jnccn.2015.0011.
[7] Zhao YP,Zhan HX,Zhang TP,et al.Surgical management of patients with insulinomas: result of 292 cases in a single institution[J].J Surg Oncol,2011,103(2):169-174.DOI:10.1002/jso.21773.
[8] Zhan HX,Cong L,Zhao YP,et al.Risk factors for the occurrence of insulinoma: a case-control study[J].Hepatobiliary Pancreat Dis Int,2013,12(3):324-328.
[9] Mafficini A,Scarpa A.Genomic landscape of pancreatic neuroendocrine tumours: the International Cancer Genome Consortium[J].J Endocrinol,2018,236(3):R161-R167.DOI:10.1530/JOE-17-0560.
[10] 中华医学会肿瘤学分会胰腺癌学组.胰腺神经内分泌肿瘤诊治专家共识[J].中华肿瘤杂志,2014,36(9):717-720.DOI:10.3760/cma.j.issn.0253-3766.2014.09.017
[11] Edge SB,Compton CC.The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM[J].ann Surg Oncol,2010,17(6):1471-1474.DOI:10.1245/s10434-010-0985-4.
[12] Doi R.Determinants of surgical resection for pancreatic neuroendocrine tumors[J].J Hepatobiliary Pancreat Sci,2015,22(8):610-617.DOI:10.1002/jhbp.224.
[13] Moris D,Tsilimigras DI,Ntanasis-Stathopoulos I,et al.Liver transplantation in patients with liver metastases from neuroendocrine tumors: a systematic review[J].Surgery,2017,162(3):525-536.DOI:10.1016/j.surg.2017.05.006.
[14] Matej A,Bujwid H,Wroński J.Glycemic control in patients with insulinoma[J].Hormones(Athens),2016,15(4):489-499.DOI:10.14310/horm.2002.1706.
[15] Buishand FO,Arkesteijn GJ,Feenstra LR,et al.Identification of CD90 as putative cancer stem cell marker and therapeutic target in insulinomas[J].Stem Cells Dev,2016,25(11):826-835.DOI:10.1089/scd.2016.0032.
[16] Queiroz Almeida M,Machado MC,Correa-Giannella ML,et al.Endogenous hyperinsulinemic hypoglycemia: diagnostic strategies, predictive features of malignancy and long-term survival[J].J Endocrinol Invest,2006,29(8):679-687.
[17] Klöppel G.Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms[J].Endocr Relat Cancer,2011,18(Suppl 1):S1-S16.DOI:10.1530/ERC-11-0013.
[18] Dromain C,Déandréis D,Scoazec JY,et al.Imaging of neuroendocrine tumors of the pancreas[J].Diagn Interv Imaging,2016,97(12):1241-1257.DOI:10.1016/j.diii.2016.07.012.
[19] Alkatout I,Friemel J,Sitek B,et al.Novel prognostic markers revealed by a proteomic approach separating benign from malignant insulinomas[J].Mod Pathol,2015,28(1):69-79.DOI:10.1038/modpathol.2014.82.